Avoro Capital Advisors LLC Merus N.V. Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
A detailed history of Avoro Capital Advisors LLC transactions in Merus N.V. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,000,000 shares of MRUS stock, worth $164 Million. This represents 2.04% of its overall portfolio holdings.
Number of Shares
3,000,000
Previous 2,125,000
41.18%
Holding current value
$164 Million
Previous $89.4 Million
41.31%
% of portfolio
2.04%
Previous 1.3%
Shares
9 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$257 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$244 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$227 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$184 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$173 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.5B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...